PMC:7289100 / 34338-34611
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T425 | 70-90 | Disease | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/MONDO_0008383 |
T426 | 81-90 | Disease | denotes | arthritis | http://purl.obolibrary.org/obo/MONDO_0005578 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T255 | 11-12 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T192 | 70-90 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T212 | 0-273 | Sentence | denotes | Similarly, a report by Monti et al. [93] suggested that patients with rheumatoid arthritis treated with biological DMARDs or targeted synthetic DMARDs did not seem to be at increased risk of life-threatening complications from Covid-19 compared with the general population. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T465 | 191-195 | UBERON:0000104 | denotes | life |
T466 | 227-235 | SP_7 | denotes | Covid-19 |
T18343 | 191-195 | UBERON:0000104 | denotes | life |
T20545 | 227-235 | SP_7 | denotes | Covid-19 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1178 | 56-64 | Species | denotes | patients | Tax:9606 |
1241 | 70-90 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
1242 | 134-150 | Disease | denotes | synthetic DMARDs | OMIM:146820 |
1243 | 227-235 | Disease | denotes | Covid-19 | MESH:C000657245 |